If one bothers to look through the OP-linked article one finds:
Notably, the prevalence of major risk factors such as consumption of unhealthy diet, physical inactivity, heavy alcohol consumption, and cigarette smoking are increasing in many parts of the world and will likely exacerbate the future burden of cancer barring any large scale interventions.
Further, if one bothers to click the article's link to the ACS study,
https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21834 , one can find:
The coronavirus disease 2019 pandemic caused over 6 million deaths in 2020–2022 and severely affected health systems worldwide. Cancer services across the cancer continuum were significantly affected, resulting in major delays in diagnosis and treatment. Many cancer registries worldwide reported disruptions to their operations during the first wave of the pandemic,182, 183 and monthly cancer registrations were clearly reduced for common cancers as a result in many countries. The estimates provided for 2022, however, do not reflect the impact of the pandemic because they are largely based on extrapolations of cancer data collected before 2020. In any case, it is difficult to develop estimates adjusted for the pandemic while the final conclusions are still to be drawn. The subsequent impact on cancer incidence counts may turn out to be rather moderate and short-term; for example, several registries have reported that, having received relatively fewer pathology reports during earlier months was offset by increased diagnostic activity in later months.184-186 Nevertheless, the long-term impact on cancer survival and mortality remains to be assessed, whereas modeling studies have predicted that a transient increase in diagnoses at more advanced stages could lead to future excess cancer mortality.
There were advances in compiling the 2022 cancer incidence estimates. First, the development of the estimates was coupled with the availability of incidence data from the latest published volume (Volume XII) of Cancer Incidence in Five Continents (CI5).187 The CI5 series is an exposition of comparable cancer incidence data from all parts of the globe based on the high-quality data made available by population-based cancer registries. For CI5 Volume XII, 671 population-based cancer registries, covering 813 populations in 104 countries, responded to the call for data, submitting cancer incidence data sets that covered the period of diagnosis from 2013 to 2017. After a careful evaluation of the comparability, completeness, and accuracy of each data set, Volume XII compiles cancer incidence data from 456 cancer registries, covering 589 populations in 70 countries.
IOW, long-known increases of cancer risk (smoking, alcohol, etc.) are increasing, and the increase in cancers was observed in years before
The Vaccine existed. Sorry, Charlies, this is not the
Vaccine Injuries you seek.
